• Genmab average ebitda margin for 2024 was 32.5%, a 13.63% increase from 2023.
• Genmab average ebitda margin for 2023 was 37.63%, a 1.84% decline from 2022.
• Genmab average ebitda margin for 2022 was 36.95%, a 18.16% increase from 2021.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.